Xeris Biopharma Holdings, Inc. (XERS) stock analysis
XERS · Xeris Biopharma Holdings, Inc.
Latest recorded price: USD 16.70
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
A reliable intrinsic value could not be calculated for XERS; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 38.3%, ROIC 27.2%.